Maria Leptin Appointed President of European Research Council

The funding agency for basic research had been led by an interim president for more than a year.

Written byShawna Williams
| 1 min read
a headshot of Maria Leptin wearing a black sweater with white background

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Developmental biologist and immunologist Maria Leptin will be the next president of the European Research Council, the ERC’s Scientific Council announced last week. Leptin will take over in October from Interim President Jean-Pierre Bourguignon, who has been leading the ERC since Mauro Ferrari resigned from the post in April 2020 after a dispute over how the organization should fund research on COVID-19.

The ERC is a major funder of basic research in Europe; according to Times Higher Education, its annual budget recently increased 22 percent under the EU’s Horizon Europe program, to €16 billion.

In a video released by the ERC, Leptin says her three main priorities as president will be stabilizing and expanding the agency’s finances; making sure that it “serves all communities,” both in terms of geography and scientific fields; and continuously updating its processes, which she calls “excellent.”

“The ERC has experienced a bit of turbulence, but ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies